alpha-aminopyridine has been researched along with Bladder, Overactive in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, H; Dong, L; He, X; Li, N; Liu, B; Liu, Y | 1 |
Hakenberg, OW; Kirschstein, T; Köhling, R; Mader, F; Porath, K; Pose, M; Protzel, C; Weller, J | 1 |
Blot, K; Falconer, C; Marschall-Kehrel, D; Michel, MC; Radziszewski, P | 1 |
Cnota, P; Hermann, R; Maus, J | 1 |
Blot, K; Michel, MC | 1 |
Szelenyi, I | 1 |
1 review(s) available for alpha-aminopyridine and Bladder, Overactive
Article | Year |
---|---|
Flupirtine, a re-discovered drug, revisited.
Topics: Aminopyridines; Analgesics; Epilepsy; Humans; KCNQ Potassium Channels; Neuralgia; Neuromuscular Agents; Urinary Bladder, Overactive | 2013 |
1 trial(s) available for alpha-aminopyridine and Bladder, Overactive
Article | Year |
---|---|
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.
Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2012 |
4 other study(ies) available for alpha-aminopyridine and Bladder, Overactive
Article | Year |
---|---|
Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.
Topics: Aminopyridines; Animals; Benzamides; Cyclopropanes; Dietary Fats; Female; Gene Expression; Interleukin-1beta; Interleukin-6; Muscle, Smooth; NF-kappa B; Obesity; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2017 |
Age-related decrease of adenosine-mediated relaxation in rat detrusor is a result of A2B receptor downregulation.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine Triphosphate; Age Factors; Aged; Aminopyridines; Animals; Disease Models, Animal; Down-Regulation; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Rats; Receptor, Adenosine A2B; Urinary Bladder, Overactive | 2015 |
Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from randomized controlled trials.
Topics: Aminopyridines; Analgesics; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Male; Urinary Bladder, Overactive | 2012 |
Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs.
Topics: Aminopyridines; Analgesics; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Male; Urinary Bladder, Overactive | 2012 |